In Vitro Hematopoiesis in Patients with Malignant Lymphoma During Active Disease and at Complete Clinical Remission After Chemotherapy

References

• Harris N L, Jaffe E S, Stein H, Banks P M, Chan J KC, Cleary M L, Delsol G, Dewolfpeeters C, Falini B, Gatter K C, Grogan T M, Isaacson P G, Knowles D M, Mason D Y, Mullerhermelink H K, Pilveri S A, Piris M A, Ralfkiaer E, Warnke R A. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 1994; 84: 1361–1365
   PubMed Web of Science ®Google Scholar
• Hiddemann W, Longo D L, Coiffer B, Fisher R I, Cabanillas E, Cavalli F, Nadler L M, de vita V T, Lister T A, Armitage J O. Lymphoma classification. The gap between biology and clinical management is closing. Blood 1996; 88: 4085–4089
   PubMed Web of Science ®Google Scholar
• Friedman D F, Cho E A, Goldman J, Carmack C E, Bexa E C, Hardy R R, Silberstein L E. The role of clonal selection in the pathogenesis of an autoreactive human B cell lymphoma. J Exp Med. 1991; 174: 525–531
   PubMed Web of Science ®Google Scholar
• Gordon L I, Harrington D, Anderson J. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. New Eng J Med. 1992; 327: 1342–1346
   PubMed Web of Science ®Google Scholar
• Fisher R I, Gaynor E R, Dahlberg S. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. New Engl J Med. 1993; 328: 1002–1005
   PubMed Web of Science ®Google Scholar
• Avilés A, Nambo M J, Talavera A. GM-CSF instead of hematological support during high dose chemotherapy for refractory malignant lymphomas. Leukemia & Lymphoma. 1995; 17: 327–330
   PubMed Web of Science ®Google Scholar
• Smalley R V, Anderson J W, Hawkins M J. Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma. New Engl J Med. 1992; 327: 1336–1340
   PubMed Web of Science ®Google Scholar
• Avilés A, Díaz-Maqueo J C, Garcia E L. Maintenance therapy with interferon alfa 2b in patients with diffuse large cell lymphoma. Invest New Drugs. 1992; 10: 351–358
   PubMed Web of Science ®Google Scholar
• Haouin C, Lepage E, Gisselbrect C. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate and high grade non-Hodgkin's lymphoma in first remission. J Clin Oncol. 1994; 12: 2543–2551
   PubMed Web of Science ®Google Scholar
• McKeithan T W. Molecular biology of Non-Hodgkin's lymphoma. Sem Oncol. 1990; 17: 30–42
   PubMed Web of Science ®Google Scholar
• Ohshima A, Miura I, Hashimoto K, Takahashi N, Ulsumi S, Nimura T, Saito M, Miki T, Hirosawa S, Miura A B. Rearrangements of the BCL6 gene and chromosome aberrations affecting 3q27 in 54 patients with non-Hodgkin's lymphoma. Leukemia & Lymphoma 1997; 27: 329–334
   PubMed Web of Science ®Google Scholar
• Garcia-Sanz R, Gonzalez M, Vargas M, Chilian M C, Balanzategui A, Barbon M, Flores M T, San Miguel J F. Deletions and rearrangements of cyclin-dependent kinase 4 inhibitor gene p16 are associated with poor prognosis in B cell non-Hodgkin's lymphomas. leukemia. 1997; 11: 1915–1920
   PubMed Web of Science ®Google Scholar
• Ngan B-Y., Chen-Levy Z, Weiss L M. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14:18) chromosomal translocation. New Engl J Med 1988; 318: 1638–1641
   PubMed Web of Science ®Google Scholar
• Xerri I, Devilard K, Hassoun J, Haddad P, Birg F. Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis. Leukemia 1997; 11: 1868–1977
   PubMed Web of Science ®Google Scholar
• Gronbaek K, Straten P, Ralfkiaer E, Ahrenkiel V, Andersen M K, Hansen N E, Zeuthen J, Hou-Jensen K, Guldberg P. Somatic Fas mutations in non-Hodgkin's lymphoma: Association with extranodal disease and autoimmunity. Blood 1998; 92: 3018–3024
   PubMed Web of Science ®Google Scholar
• Avilés A, Calva A, Díaz-Maqueo J C, Talavera A, Huerta-Guzman I, Vasquez E. Dose escalation of epirubicin in the CEOP-BLEO regimen: A controlled clinical trial comparing standard doses for the treatment of diffuse large cell lymphoma. Leukemia & Lymphoma 1997; 25: 319–325
   PubMed Web of Science ®Google Scholar
• Mayani H, Guilbert L J, Janowska-Wieczorek A. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoiesis in human long-term marrow cultures. Exp Hematol 1990; 18: 174–179
   PubMed Web of Science ®Google Scholar
• Mayani H, Gutierrez-Rodriguez M, Espinoza L, López-Chalini E, Huerta-Zepeda A, Flores F, Sanchez-Valle E, Luna-Bautista F, Valencia I, Ramirez O T. Kinetics of hematopoiesis in Dexter-type long-term cultures established from human umbilical cord blood cells. Stem Cells. 1998; 16: 127–135
   PubMed Web of Science ®Google Scholar
• Castro-Malaspina H, Gay R E, Resnick G. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980; 56: 289–301
   PubMed Web of Science ®Google Scholar
• Griffin J D, Lowenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood 1986; 68: 1185–1195
   PubMed Web of Science ®Google Scholar
• Gómez-Morales H, Martinez-Jaramillo G, Sanchez-Valle E, Valencia-Plata I, Ama-Trejo R M, Castro M A, Pizuto-Chavez J, Mayani H. Deficient proliferation of myeloid. erythroid and multipotent progenitor cells in long-term marrow cultures from patients with aplastic anemia treated with immunosuppressive therapy. Am J Hematol 1998; 59: 149–155
   PubMed Web of Science ®Google Scholar
• Flores-Figueroa E, Gutiérrez-Espindola G, Guerrero-Rivera S, Pizzulo-Chavez J, Mayani H. Hematopoietic progenitor cells from patients with myelodysplastic syndromes: In vitro colony growth and long-term proliferation. Leuk Res. 1999; 23: 387–396
   Web of Science ®Google Scholar
• Sutherland H J, Lansdorp P M, Henkelman D H, Eaves A C, Eaves C J. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA 1990; 87: 3584–3588
   PubMed Web of Science ®Google Scholar
• Soligo D A, Lambertenghi Delilieris G, Servida F, Quirici N, Campiglio S, Tagliaferri E, Oriani A, Romitti L, Della Volpe A, Annaloro C. Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients. Bone Marrow Transplant. 1998; 21: 15–22
   PubMed Web of Science ®Google Scholar
• Bhavnani M, Morris Jones P H, Testa N G. Children in long-term remission after treatment for acute lymphoblastic leukemia show persisting haemopoietic injury in clonal and long-term cultures. Br J Haematol 1989; 71: 37–41
   PubMed Web of Science ®Google Scholar
• Radford J A, Testa N G, Crowther D. The long-term effects of MVPP Chemotherapy for Hodgkin's disease on bone marrow function. Br J Cancer 1990; 62: 127–132
   PubMed Web of Science ®Google Scholar
• Roingeard F, Binet C, Lecron J C, Truglio D, Colombat P, Domenech J. Cytokines released in vitro by stromal cells from autologous bone marrow transplant patients with lymphoid malignancy. Eur J Haematol 1998; 61: 100–108
   PubMed Web of Science ®Google Scholar
• Testa N G, Gale R P. Hematopoiesis: Long-term effects of chemotherapy and radiation. Marcel Dekker, New York 1988
   Google Scholar
• Domenech J, Gihana E, Dayan A, Truglio D, Linassier C, Desbois I, Lamagnere J P, Colombat P, Binet C. Haemopoiesis of transplanted patients with autologous marrows assessed by long-term marrow cultures. Br J Haematol 1994; 88: 488–496
   PubMed Web of Science ®Google Scholar